54.8 F
Laguna Hills
Friday, Apr 3, 2026
-Advertisement-

Cryoport Soared to Best-Performing Stock of Bunch

Now the envelopes for the five best- and five worst-performing stocks during the year ended March 29:

• Taking the top spot was Cryoport Inc. (Nasdaq: CYRX), which climbed 264% to $8.60 and a $235 million market cap.

The Irvine-based company reported a 56% jump in 2017 revenue to $12 million and predicted “significant revenue growth” in the coming quarters. It improved systems, hired more people and entered into long-term logistics agreements. Cryoport also cut its annual loss 40% to $7.9 million.

“2017 was an inflection point for our company,” Chief Executive Jerrell Shelton said in its annual statement.

It sees itself as “the logistical backbone of the regenerative medicine industry.” It uses cryogenic technology to ship a range of life sciences products domestically and internationally, including immunotherapies and stem, CAR-T and reproductive cells.

• In second place is Irvine-based Alteryx Inc. (NYSE: AYX), which more than doubled its share price to $34.19 and now has a $2.1 billion market cap. After an initial public offering in March 2017 at $14 a share, it briefly fell as low as $14.80 before beginning a steady climb (see photo, page 1).

Alteryx reported 2017 revenue climbed 53% to $132 million. The company predicts sales will increase this year by as much as 36%.

It calls itself a “leader in self service data analytics” that can prep, blend and analyze data in hours instead of weeks. The company offers an end-to-end analytics platform for 3,400 customers in the enterprise sector, including blue-chippers like Best Buy, The Home Depot Inc. and McDonald’s.

• In third place is the 79% jump of Boot Barn Inc. (NYSE: BOOT), a retailer that’s bucking the industry trend by increasing store count (see story, page 1).

• Barely behind in fourth place is Kush Bottles Inc. (OTCQB: KSHB), up 79% to $5 and a $318 million market cap.

Its stock was a drag for much of the year until November, when someone on Wall Street got a whiff that Kush was a key supplier of paraphernalia to the industry around cannabis, which California legalized in January when voters passed Proposition 64. The stock reached as high as $8.51 in early January before the buzz wore off.

The Santa Ana-based company reported first-quarter revenue soared 258% to $8.85 million for the period ended Nov. 30. It’s scheduled to report second-quarter results this week.

• ICU Medical Inc. (Nasdaq: ICUI), takes fifth place with a 65% increase to $252.40 and a $5.1 billion market cap. The medical devices provider acquired the Hospira Infusion System business of Pfizer Inc. a year ago, permitting the San Clemente-based company to almost quadruple sales last year.

Shares climbed steadily throughout the year, aided by a 9.2% bump last month after it boosted its 2018 profit forecast.

Special note: The best performing penny stock on our list was Propel Media Inc. (OTC: PROM), an online advertising company with 54 employees that became public through a reverse merger in 2015. Shares of the Irvine-based company climbed from 2.69 cents to 30 cents, a 1,015% gain, in the 12 months ended March 29. Its market cap jumped to $75 million, good for No. 62 on the list.

Revenue in 2017 climbed 45% to $88.7 million with a net loss of $363,000 for the year due to expenses such as $12.2 million for interest payment and $18.1 million for income tax, Propel Media said in its annual report. The company has a $58.3 million term loan with a 10.2% annual interest rate due next January.

The Shouldn’t Haves

Now for the five worst performers:

• No. 5, Glaukos Corp. (NYSE: GKOS), reached its all-time high last April, $52.39, then fell 40% to $30.83 and a $1.07 billion market cap. The San Clemente-based maker of products to treat glaucoma suffered its biggest drop, 18%, on Sept. 14 after cutting its 2017 revenue forecast.

•(Nasdaq: ELGX), which declined 42% to $4.23 and a $354 million market cap. Shares of the maker of endovascular stent grafts plummeted 37% on May 18 after the Irvine-based company said potential Food and Drug Administration approval of its next-generation Nellix System will be delayed two years longer than investors anticipated.

• The Street didn’t like the taste of third place The Habit Restaurants Inc. (NASDAQ: HABT), which fell 50% to $8.80 and a $229 million market cap. Shares dropped 25% on Nov. 2 after the Irvine-based fast-casual burger chain reported third-quarter same-store sales decreased 0.2% year-over-year. Shares had soared above $40 in 2014.

• AutoWeb Inc. (Nasdaq: AUTO) suffered a flat tire as shares plummeted 76% to $2.98 and a $39 million market cap. The automobile sales leads provider reported two big blows during the year. Shares dropped 24% on Aug. 4 after the Irvine-based company cut its 2017 revenue and profit forecasts. They fell another 42% on March 9 after it reported fourth-quarter revenue declined and that longtime Chief Executive Jeff Coats and Chief Financial Officer Kimberly Boren were leaving the company.

• Bringing up the rear is Netlist Inc. (NASDAQ: NLST), an Irvine-based maker of modular memory subsystems. It fell 77% to 23 cents a share and a $16 million market cap. Stock plummeted in August after the company said it would issue new shares, which were eventually priced at 60 cents each, about half the price it traded at a week earlier.

The stock further plunged in November after it lost an infringement case against SK Hynix. It traded above $10 at its historic high in 2006.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

  • Unlimited access to OCBJ.com
  • Daily OCBJ Updates delivered via email each weekday morning
  • Journal issues in both print and digital format
  • The annual Book of Lists: industry of Orange County's leading companies
  • Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Peter J. Brennan
Peter J. Brennan
With four decades of experience in journalism, Peter J. Brennan has built a career that spans diverse news topics and global coverage. From reporting on wars, narcotics trafficking, and natural disasters to analyzing business and financial markets, Peter’s work reflects a commitment to impactful storytelling. Peter’s association with the Orange County Business Journal began in 1997, where he worked until 2000 before moving to Bloomberg News. During his 15 years at Bloomberg, his reporting often influenced financial markets, with headlines and articles moving the market caps of major companies by hundreds of millions of dollars. In 2017, Peter returned to the Orange County Business Journal as Financial Editor, bringing his heavy business industry expertise. Over the years, he advanced to Executive Editor and, in 2024, was named Editor-in-Chief. Peter’s work has been featured in prestigious publications such as The New York Times and The Washington Post, and he has appeared on CNN, CBC, BBC, and Bloomberg TV. A Kiplinger Fellowship recipient at The Ohio State University, he leads the Business Journal with a dedication to uncovering stories that matter and shaping the local business community and beyond.
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-